

V-9-M Cholecystokinin nonapeptide
V-9-M Cholecystokinin nonapeptide
Catalog No. M37925
V-9-M Cholecystokinin nonapeptide (Prepro CCK Fragment V-9-M) is a precursor compound of cholecystokinin (CCK).
Size | Price / USD | Stock | Quantity |
2MG | 59 | In Stock |
![]() ![]() |
5MG | 76 | In Stock |
![]() ![]() |
10MG | 116 | In Stock |
![]() ![]() |
25MG | 181 | In Stock |
![]() ![]() |
50MG | 273 | In Stock |
![]() ![]() |
100MG | 408 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameV-9-M Cholecystokinin nonapeptide
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. A Funakoshi, et al. Expression of the cholecystokinin precursor gene in rat tissues. J Gastroenterol. 1994 Apr;29(2):125-8.?
molnova catalog



related products
-
δ-secretase inhibito...
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
-
Amyloid β-Protein 10...
Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.Amyloid β protein fragment containing the α-secretase processing site (Lys16-Leu17 bond). It also contains the HHQK domain (residues 13-16) responsible for binding to microglial cells.
-
PPI-1019
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).